[Bronchodilator treatment of COPD].
作者信息
Naberan K
机构信息
Universidad de Barcelona.
出版信息
Aten Primaria. 1998 Feb 15;21(2):109-13.
PMID:9608136
Abstract
摘要
相似文献
1
[Bronchodilator treatment of COPD].
Aten Primaria. 1998 Feb 15;21(2):109-13.
2
[Treatment of COPD in primary care].
Arch Bronconeumol. 2000 Mar;36(3):167.
3
Bronchodilating effects of combined therapy with clinical dosages of ipratropium bromide and salbutamol for stable COPD.
Chest. 1996 Jan;109(1):294. doi: 10.1378/chest.109.1.294.
4
The position of theophylline in the treatment of asthma and chronic obstructive pulmonary disease.
Neth J Med. 1995 May;46(5):213-6. doi: 10.1016/0300-2977(94)00103-0.
5
Bronchodilating effects of combined therapy with clinical dosages of ipratropium bromide and salbutamol for stable COPD.
Chest. 1996 Jan;109(1):293. doi: 10.1378/chest.109.1.293-a.
6
A multicenter study of nebulized bronchodilator solutions in chronic obstructive pulmonary disease.
Am J Med. 1996 Jan 29;100(1A):30S-39S. doi: 10.1016/s0002-9343(96)80061-1.
7
Bronchodilator therapy in chronic obstructive pulmonary disease.
Curr Opin Pulm Med. 2000 Mar;6(2):99-103. doi: 10.1097/00063198-200003000-00003.
8
Results of a multicenter study of nebulized inhalant bronchodilator solutions.
Am J Med. 1996 Jan 29;100(1A):62S-69. doi: 10.1016/s0002-9343(96)80109-4.
9
Changing practices in COPD. A new pharmacologic treatment algorithm.
Chest. 1995 May;107(5 Suppl):194S-197S. doi: 10.1378/chest.107.5_supplement.194s.
10
[Broncholytic activity of dose-adjusted aerosols in active respiratory tuberculosis].
Probl Tuberk. 1995(2):7-9.
引用本文的文献
1
Inhaled short-acting beta2-agonists versus ipratropium for acute exacerbations of chronic obstructive pulmonary disease.
Cochrane Database Syst Rev. 2001;2001(2):CD002984. doi: 10.1002/14651858.CD002984.
Zotero 插件